Attovia Therapeutics Launches With $60 Million Series A Financing To Unlock Potential Of Novel Biparatopic Nanobody Platform
Amount Raised
$60 Million
Round Type
Series A
FremontBiotechnologyTherapeuticsDescription
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of diseases, and Frazier Life Sciences, announced the launch of Attovia Therapeutics, a newly formed company focused on creating a pipeline of biotherapeutics in immune-mediated disease and cancer. The company, based on AttobodyTM, Alamar’s novel proprietary biparatopic nanobody platform, concurrently closed a $60 million Series A financing led by Frazier and joined by venBio and Illumina Ventures.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Attovia Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- PredxBio raised $601K (Seed) on August 4, 2023.
- Oragenics raised $850K (Series C) on August 4, 2023.
- Ikena Oncology raised $43M on August 4, 2023.
- Amber Bio raised $26M (Seed) on August 3, 2023.
- ADARx Pharmaceuticals, Inc. raised $200M on August 2, 2023.
- Solu Therapeutics raised an undisclosed amount (Seed) on August 1, 2023.
Who to call at Attovia Therapeutics, and when
A new round usually means Attovia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Attovia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Attovia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Attovia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Attovia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAttovia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.